Ensoma
Clinical trials sponsored by Ensoma, explained in plain language.
-
New gene therapy aims to fix immune system in rare disease
Disease control Recruiting nowThis study tests a new gene therapy called EN-374 for people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder that leads to severe infections. The treatment uses a modified virus to deliver a working gene to help the body produce infection-fighting cell…
Phase: PHASE1, PHASE2 • Sponsor: Ensoma • Aim: Disease control
Last updated May 26, 2026 10:59 UTC
-
New study probes immune system clues in rare disease patients
Knowledge-focused Recruiting nowThis study measures levels of adenovirus-fighting antibodies and inflammatory markers in the blood of 60 adults and children with chronic granulomatous disease (CGD). The goal is to better understand the immune response in CGD, which may help design future treatments. Participant…
Sponsor: Ensoma • Aim: Knowledge-focused
Last updated May 26, 2026 11:04 UTC